SIMILAR PATTERNS OF AMINO ACIDS FOR 4NNR_B_FK5B201
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eom | ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F3 (Elizabethkingiameningoseptica) |
PF00704(Glyco_hydro_18) | 5 | ASP A 34VAL A 284ILE A 271TYR A 274ILE A 29 | None | 1.33A | 4nnrB-1eomA:undetectable | 4nnrB-1eomA:17.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | PHE A 153ILE A 159TRP A 162TYR A 185ILE A 194PHE A 202 | None | 1.14A | 4nnrB-1fd9A:13.2 | 4nnrB-1fd9A:25.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 8 | TYR A 131ASP A 142VAL A 158ILE A 159TRP A 162TYR A 185ILE A 194PHE A 202 | None | 0.67A | 4nnrB-1fd9A:13.2 | 4nnrB-1fd9A:25.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 9 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82ILE A 91PHE A 99 | None | 0.58A | 4nnrB-1fkkA:16.2 | 4nnrB-1fkkA:39.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gaj | HIGH-AFFINITYBRANCHED CHAIN AMINOACID TRANSPORTATP-BINDING PROTEIN (Methanocaldococcusjannaschii) |
PF00005(ABC_tran) | 5 | ASP A 178PHE A 88VAL A 85ILE A 175ILE A 208 | None | 1.40A | 4nnrB-1gajA:undetectable | 4nnrB-1gajA:22.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hxj | BETA-GLUCOSIDASE (Zea mays) |
PF00232(Glyco_hydro_1) | 5 | TYR A 163PHE A 151VAL A 140TRP A 96PHE A 166 | None | 1.35A | 4nnrB-1hxjA:undetectable | 4nnrB-1hxjA:14.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1i4s | RIBONUCLEASE III (Aquifexaeolicus) |
PF14622(Ribonucleas_3_3) | 5 | ASP A 138PHE A 109VAL A 47ILE A 51PHE A 79 | None | 1.37A | 4nnrB-1i4sA:undetectable | 4nnrB-1i4sA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1icp | 12-OXOPHYTODIENOATEREDUCTASE 1 (Solanumlycopersicum) |
PF00724(Oxidored_FMN) | 5 | TYR A 300PHE A 304VAL A 275ILE A 240ILE A 186 | None | 1.39A | 4nnrB-1icpA:undetectable | 4nnrB-1icpA:15.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 6 | PHE A 114ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 1.01A | 4nnrB-1jvwA:12.4 | 4nnrB-1jvwA:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 6 | TYR A 92ASP A 103ILE A 120TYR A 146ILE A 155PHE A 163 | None | 0.68A | 4nnrB-1jvwA:12.4 | 4nnrB-1jvwA:32.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 7 | TYR A 92VAL A 119ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.49A | 4nnrB-1jvwA:12.4 | 4nnrB-1jvwA:32.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 5 | PHE A 77VAL A 86ILE A 87TRP A 90LYS A 121 | None | 0.99A | 4nnrB-1kt1A:12.2 | 4nnrB-1kt1A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 5 | PHE A 77VAL A 86TRP A 90LYS A 121ILE A 122 | None | 0.83A | 4nnrB-1kt1A:12.2 | 4nnrB-1kt1A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 7 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.86A | 4nnrB-1kt1A:12.2 | 4nnrB-1kt1A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 6 | TYR A 57PHE A 77VAL A 86TRP A 90TYR A 113ILE A 122 | None | 1.48A | 4nnrB-1kt1A:12.2 | 4nnrB-1kt1A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1l6j | MATRIXMETALLOPROTEINASE-9 (Homo sapiens) |
PF00040(fn2)PF00413(Peptidase_M10)PF01471(PG_binding_1) | 5 | TYR A 262ASP A 266PHE A 236TRP A 255PHE A 268 | None | 1.26A | 4nnrB-1l6jA:undetectable | 4nnrB-1l6jA:14.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n1a | FKBP52 (Homo sapiens) |
PF00254(FKBP_C) | 10 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113LYS A 121ILE A 122PHE A 130 | None | 0.70A | 4nnrB-1n1aA:15.0 | 4nnrB-1n1aA:41.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pbk | FKBP25 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.26A | 4nnrB-1pbkA:15.6 | 4nnrB-1pbkA:38.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | PHE A 168ILE A 174TRP A 177TYR A 200ILE A 208PHE A 216 | None | 1.32A | 4nnrB-1q6hA:13.6 | 4nnrB-1q6hA:27.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 8 | TYR A 146ASP A 157VAL A 173ILE A 174TRP A 177TYR A 200ILE A 208PHE A 216 | None | 0.61A | 4nnrB-1q6hA:13.6 | 4nnrB-1q6hA:27.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 8 | TYR A 40ASP A 51VAL A 69ILE A 70TRP A 73TYR A 96ILE A 105PHE A 113 | None | 0.67A | 4nnrB-1r9hA:16.2 | 4nnrB-1r9hA:42.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 8 | TYR A 40PHE A 60VAL A 69ILE A 70TRP A 73TYR A 96ILE A 105PHE A 113 | None | 0.47A | 4nnrB-1r9hA:16.2 | 4nnrB-1r9hA:42.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rc7 | RIBONUCLEASE III (Aquifexaeolicus) |
PF00035(dsrm)PF14622(Ribonucleas_3_3) | 5 | ASP A 138PHE A 109VAL A 47ILE A 51PHE A 79 | None | 1.30A | 4nnrB-1rc7A:undetectable | 4nnrB-1rc7A:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ry2 | ACETYL-COENZYME ASYNTHETASE 1 (Saccharomycescerevisiae) |
PF00501(AMP-binding)PF13193(AMP-binding_C)PF16177(ACAS_N) | 5 | PHE A 349VAL A 466ILE A 465TYR A 454ILE A 458 | None | 1.06A | 4nnrB-1ry2A:undetectable | 4nnrB-1ry2A:12.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sa3 | TYPE II RESTRICTIONENZYME MSPI (Moraxella sp.) |
PF09208(Endonuc-MspI) | 5 | TYR A 214ASP A 216ILE A 38ILE A 219PHE A 207 | None | 1.39A | 4nnrB-1sa3A:undetectable | 4nnrB-1sa3A:21.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1u79 | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE3 (Arabidopsisthaliana) |
PF00254(FKBP_C) | 8 | TYR A 37ASP A 48VAL A 66ILE A 67TRP A 70TYR A 99ILE A 113PHE A 121 | None | 0.51A | 4nnrB-1u79A:14.6 | 4nnrB-1u79A:37.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yat | FK506 BINDINGPROTEIN (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 9 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82ILE A 91PHE A 99 | FK5 A 108 ( 4.0A)FK5 A 108 ( 3.3A)FK5 A 108 ( 4.0A)FK5 A 108 ( 3.4A)FK5 A 108 ( 3.7A)FK5 A 108 ( 3.6A)FK5 A 108 ( 4.7A)NoneNone | 0.21A | 4nnrB-1yatA:16.7 | 4nnrB-1yatA:40.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ihm | DNA POLYMERASE MU (Mus musculus) |
PF10391(DNA_pol_lambd_f)PF14716(HHH_8)PF14791(DNA_pol_B_thumb)PF14792(DNA_pol_B_palm) | 5 | PHE A 179VAL A 212ILE A 213LYS A 187PHE A 205 | None | 1.24A | 4nnrB-2ihmA:undetectable | 4nnrB-2ihmA:17.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2lpv | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Aedes aegypti) |
PF00254(FKBP_C) | 5 | TYR A 27ILE A 57TRP A 60ILE A 92PHE A 100 | None | 1.30A | 4nnrB-2lpvA:13.2 | 4nnrB-2lpvA:39.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2lpv | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Aedes aegypti) |
PF00254(FKBP_C) | 5 | TYR A 27PHE A 47ILE A 57TRP A 60ILE A 92 | None | 1.08A | 4nnrB-2lpvA:13.2 | 4nnrB-2lpvA:39.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2lpv | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Aedes aegypti) |
PF00254(FKBP_C) | 5 | TYR A 27VAL A 56ILE A 57TRP A 60ILE A 92 | None | 1.05A | 4nnrB-2lpvA:13.2 | 4nnrB-2lpvA:39.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 86TRP A 89TYR A 112ILE A 121PHE A 129 | PEG A 201 (-4.4A)NonePEG A 201 ( 3.9A)PEG A 201 (-3.6A)PEG A 201 (-3.8A)PEG A 201 (-3.7A)NoneNoneNone | 0.70A | 4nnrB-2pbcA:18.9 | 4nnrB-2pbcA:71.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.76A | 4nnrB-2vcdA:10.7 | 4nnrB-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.76A | 4nnrB-2vcdA:10.7 | 4nnrB-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.62A | 4nnrB-2vcdA:10.7 | 4nnrB-2vcdA:30.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vn1 | 70 KDAPEPTIDYLPROLYLISOMERASE (Plasmodiumfalciparum) |
PF00254(FKBP_C) | 9 | TYR A 44ASP A 56PHE A 65VAL A 74ILE A 75TRP A 78TYR A 101ILE A 110PHE A 118 | FK5 A 501 (-4.1A)FK5 A 501 (-3.4A)FK5 A 501 (-4.1A)FK5 A 501 (-3.5A)FK5 A 501 (-4.3A)FK5 A 501 (-3.3A)FK5 A 501 (-4.7A)NoneFK5 A 501 (-4.8A) | 0.23A | 4nnrB-2vn1A:16.0 | 4nnrB-2vn1A:38.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 7 | TYR A 33ASP A 44PHE A 53ILE A 63TYR A 89ILE A 98PHE A 106 | None | 0.74A | 4nnrB-2y78A:15.7 | 4nnrB-2y78A:44.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 8 | TYR A 33PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | None | 0.50A | 4nnrB-2y78A:15.7 | 4nnrB-2y78A:44.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zwi | ALPHA-/BETA-GALACTOSIDEALPHA-2,3-SIALYLTRANSFERASE (Photobacteriumphosphoreum) |
PF11477(PM0188) | 5 | TYR A 251PHE A 250ILE A 339LYS A 262ILE A 261 | None | 1.08A | 4nnrB-2zwiA:undetectable | 4nnrB-2zwiA:16.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3aib | GLUCOSYLTRANSFERASE-SI (Streptococcusmutans) |
PF02324(Glyco_hydro_70) | 5 | ASP A 883VAL A 877ILE A 878LYS A 948ILE A 950 | None | 1.37A | 4nnrB-3aibA:undetectable | 4nnrB-3aibA:10.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b7x | FK506-BINDINGPROTEIN 6 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 61ASP A 73TYR A 118ILE A 127PHE A 135 | None | 0.94A | 4nnrB-3b7xA:11.6 | 4nnrB-3b7xA:31.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i9f | PUTATIVE TYPE 11METHYLTRANSFERASE (Sulfolobussolfataricus) |
PF08241(Methyltransf_11) | 5 | TYR A 147ASP A 126PHE A 151VAL A 122ILE A 123 | None | 1.31A | 4nnrB-3i9fA:undetectable | 4nnrB-3i9fA:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57ASP A 68VAL A 86ILE A 87TYR A 113LYS A 121ILE A 122PHE A 130 | None | 1.06A | 4nnrB-3o5dA:15.3 | 4nnrB-3o5dA:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113LYS A 121ILE A 122PHE A 130 | None | 0.85A | 4nnrB-3o5dA:15.3 | 4nnrB-3o5dA:27.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57ASP A 68VAL A 86ILE A 87TYR A 113LYS A 121ILE A 122PHE A 130 | None | 0.92A | 4nnrB-3o5eA:15.6 | 4nnrB-3o5eA:43.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113LYS A 121ILE A 122PHE A 130 | None | 0.85A | 4nnrB-3o5eA:15.6 | 4nnrB-3o5eA:43.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 9 | TYR A 43ASP A 55PHE A 64VAL A 73ILE A 74TRP A 77TYR A 100ILE A 109PHE A 117 | None | 0.70A | 4nnrB-3pa7A:15.3 | 4nnrB-3pa7A:39.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s48 | IRON-REGULATEDSURFACE DETERMINANTPROTEIN H (Staphylococcusaureus) |
PF05031(NEAT) | 5 | TYR A 138ASP A 136VAL A 173ILE A 185LYS A 132 | None | 1.25A | 4nnrB-3s48A:undetectable | 4nnrB-3s48A:17.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3um6 | BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE (Plasmodiumfalciparum) |
PF00186(DHFR_1)PF00303(Thymidylat_synt) | 5 | TYR A 569VAL A 210ILE A 224TYR A 226ILE A 200 | None | 1.22A | 4nnrB-3um6A:undetectable | 4nnrB-3um6A:12.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 6 | ASP A 324ILE A 342TRP A 345TYR A 368ILE A 376PHE A 384 | None | 0.85A | 4nnrB-4bf8A:13.7 | 4nnrB-4bf8A:35.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | TYR A 313ASP A 324VAL A 341ILE A 342TRP A 345TYR A 368PHE A 384 | None | 0.86A | 4nnrB-4bf8A:13.7 | 4nnrB-4bf8A:35.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 5 | TYR A 313PHE A 332ILE A 342TRP A 345PHE A 384 | None | 1.03A | 4nnrB-4bf8A:13.7 | 4nnrB-4bf8A:35.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ckm | SAS-6 (Leishmaniamajor) |
PF16531(SAS-6_N) | 5 | TYR A 196PHE A 209VAL A 173ILE A 263PHE A 199 | None | 1.39A | 4nnrB-4ckmA:undetectable | 4nnrB-4ckmA:22.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dg5 | PHOSPHOGLYCERATEKINASE (Staphylococcusaureus) |
PF00162(PGK) | 5 | PHE A 305VAL A 263ILE A 262LYS A 206ILE A 210 | None | 1.24A | 4nnrB-4dg5A:undetectable | 4nnrB-4dg5A:17.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dip | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 52TRP A 88TYR A 111LYS A 118ILE A 119PHE A 127 | None | 0.83A | 4nnrB-4dipA:16.5 | 4nnrB-4dipA:40.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dz3 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 9 | TYR A 33ASP A 44PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | FK5 A 201 ( 3.9A)FK5 A 201 (-3.5A)FK5 A 201 (-4.1A)FK5 A 201 ( 3.6A)FK5 A 201 (-3.8A)FK5 A 201 (-3.4A)FK5 A 201 (-4.7A)NoneFK5 A 201 (-4.8A) | 0.22A | 4nnrB-4dz3A:16.7 | 4nnrB-4dz3A:45.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h09 | HYPOTHETICAL LEUCINERICH REPEAT PROTEIN (Eubacteriumventriosum) |
PF13306(LRR_5) | 5 | PHE A 337VAL A 346ILE A 369ILE A 375PHE A 383 | None | 1.25A | 4nnrB-4h09A:undetectable | 4nnrB-4h09A:18.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 6 | PHE A 46VAL A 55ILE A 56TYR A 82ILE A 91PHE A 99 | None | 0.68A | 4nnrB-4iqcA:15.7 | 4nnrB-4iqcA:35.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 26ASP A 37ILE A 56TYR A 82ILE A 91PHE A 99 | None | 0.79A | 4nnrB-4iqcA:15.7 | 4nnrB-4iqcA:35.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 26PHE A 46ILE A 56TYR A 82ILE A 91PHE A 99 | None | 0.79A | 4nnrB-4iqcA:15.7 | 4nnrB-4iqcA:35.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iyk | UNCHARACTERIZEDPROTEIN (Bacteroidesuniformis) |
PF12866(DUF3823) | 5 | VAL A 111ILE A 30TYR A 76ILE A 53PHE A 103 | None | 1.39A | 4nnrB-4iykA:undetectable | 4nnrB-4iykA:20.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.71A | 4nnrB-4lawA:15.8 | 4nnrB-4lawA:32.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.54A | 4nnrB-4lawA:15.8 | 4nnrB-4lawA:32.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4msp | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C)PF13499(EF-hand_7) | 6 | TYR A 33TRP A 69TYR A 92LYS A 99ILE A 100PHE A 108 | None | 0.83A | 4nnrB-4mspA:16.8 | 4nnrB-4mspA:32.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odm | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD (Thermusthermophilus) |
PF00254(FKBP_C) | 5 | TYR A 13ASP A 23ILE A 37TYR A 63PHE A 128 | None | 0.47A | 4nnrB-4odmA:13.2 | 4nnrB-4odmA:21.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA (Homo sapiens;Thermusthermophilus) |
PF00254(FKBP_C) | 6 | TYR A 13ASP A 23ILE A 37TYR A 63ILE A 72PHE A 80 | FK5 A 201 ( 3.6A)FK5 A 201 (-3.6A)FK5 A 201 (-3.9A)FK5 A 201 (-4.4A)NoneFK5 A 201 ( 4.8A) | 0.35A | 4nnrB-4odrA:15.2 | 4nnrB-4odrA:28.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4opw | UNCHARACTERIZEDPROTEIN (Parabacteroidesmerdae) |
PF10988(DUF2807) | 5 | ASP A 68VAL A 49ILE A 50ILE A 65PHE A 88 | NoneNoneNoneNoneEDO A 301 (-4.3A) | 1.13A | 4nnrB-4opwA:undetectable | 4nnrB-4opwA:18.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 57ASP A 68ILE A 87TYR A 113ILE A 122PHE A 130 | None | 0.71A | 4nnrB-4r0xA:15.9 | 4nnrB-4r0xA:40.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.70A | 4nnrB-4r0xA:15.9 | 4nnrB-4r0xA:40.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rv7 | DIADENYLATE CYCLASE (Listeriamonocytogenes) |
PF02457(DisA_N) | 5 | ASP A 41VAL A 113ILE A 110LYS A 77ILE A 75 | None | 1.42A | 4nnrB-4rv7A:undetectable | 4nnrB-4rv7A:21.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4tvs | TORSIN-1A-INTERACTING PROTEIN 1 (Homo sapiens) |
PF05609(LAP1C) | 5 | TYR A 495ASP A 462PHE A 469ILE A 444PHE A 492 | None | 1.43A | 4nnrB-4tvsA:undetectable | 4nnrB-4tvsA:21.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wat | PFRH5 (Plasmodiumfalciparum) |
no annotation | 5 | ASP A 440ILE A 368TYR A 360LYS A 443ILE A 442 | None | 1.36A | 4nnrB-4watA:undetectable | 4nnrB-4watA:14.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zmh | UNCHARACTERIZEDPROTEIN (Saccharophagusdegradans) |
PF15979(Glyco_hydro_115) | 5 | ASP A 944PHE A 845ILE A 840TYR A 459ILE A 883 | None | 1.21A | 4nnrB-4zmhA:undetectable | 4nnrB-4zmhA:8.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b2o | CRISPR-ASSOCIATEDENDONUCLEASE CAS9 (Francisellatularensis) |
no annotation | 5 | PHE A1576VAL A1561ILE A1547TYR A1549ILE A1611 | None | 1.17A | 4nnrB-5b2oA:undetectable | 4nnrB-5b2oA:6.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 9 | TYR C 36ASP C 56PHE C 64VAL C 73ILE C 74TRP C 77TYR C 100ILE C 109PHE C 117 | FK5 C 201 (-4.1A)FK5 C 201 ( 3.8A)FK5 C 201 (-3.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A)FK5 C 201 (-4.5A)NoneFK5 C 201 (-4.7A) | 0.37A | 4nnrB-5b8iC:15.7 | 4nnrB-5b8iC:36.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5crj | TRANSCRIPTIONTERMINATION FACTOR1, MITOCHONDRIAL (Homo sapiens) |
PF02536(mTERF) | 5 | TYR O 317ILE O 296LYS O 331ILE O 332PHE O 313 | None | 1.08A | 4nnrB-5crjO:undetectable | 4nnrB-5crjO:17.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7p | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82PHE A 146 | None | 0.59A | 4nnrB-5i7pA:14.4 | 4nnrB-5i7pA:30.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7q | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPE 16KDA PEPTIDYL-PROLYLCIS-TRANSISOMERASE,PEPTIDYL-PROLYL CIS-TRANSISOMERASE FKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 26ASP A 37VAL A 55ILE A 56TRP A 59TYR A 82PHE A 147 | None | 0.52A | 4nnrB-5i7qA:14.7 | 4nnrB-5i7qA:31.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7q | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPE 16KDA PEPTIDYL-PROLYLCIS-TRANSISOMERASE,PEPTIDYL-PROLYL CIS-TRANSISOMERASE FKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 26PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82PHE A 147 | None | 0.51A | 4nnrB-5i7qA:14.7 | 4nnrB-5i7qA:31.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 7 | ASP A 41PHE A 50VAL A 59ILE A 60TRP A 63TYR A 97ILE A 102 | None | 1.37A | 4nnrB-5i98A:15.4 | 4nnrB-5i98A:36.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 9 | TYR A 30ASP A 41PHE A 50VAL A 59ILE A 60TRP A 63TYR A 97ILE A 106PHE A 114 | None | 0.61A | 4nnrB-5i98A:15.4 | 4nnrB-5i98A:36.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j1s | TORSIN-1A-INTERACTING PROTEIN 2 (Homo sapiens) |
PF05609(LAP1C) | 5 | TYR B 381ASP B 348PHE B 355ILE B 330PHE B 378 | None | 1.41A | 4nnrB-5j1sB:undetectable | 4nnrB-5j1sB:20.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j6e | FK506-BINDINGPROTEIN 1A (Aspergillusfumigatus) |
PF00254(FKBP_C) | 9 | TYR A 27ASP A 38PHE A 47VAL A 56ILE A 57TRP A 60TYR A 83ILE A 92PHE A 100 | None | 0.63A | 4nnrB-5j6eA:16.2 | 4nnrB-5j6eA:42.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jcv | LMO2181 PROTEIN (Listeriamonocytogenes) |
PF04203(Sortase) | 5 | ASP A 125VAL A 75ILE A 89TYR A 161ILE A 221 | None | 1.03A | 4nnrB-5jcvA:undetectable | 4nnrB-5jcvA:17.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lzk | PROTEIN FAM83B (Homo sapiens) |
PF07894(DUF1669) | 5 | VAL A 167ILE A 166LYS A 136ILE A 139PHE A 157 | NoneNoneNoneEDO A 307 ( 4.9A)None | 0.94A | 4nnrB-5lzkA:undetectable | 4nnrB-5lzkA:21.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5m99 | ALPHA-AMYLASE (Thermotogapetrophila) |
PF00128(Alpha-amylase) | 5 | ASP B 213VAL B 195ILE B 198TYR B 88ILE B 85 | EDO B 616 ( 2.8A)NoneNoneNoneNone | 1.18A | 4nnrB-5m99B:undetectable | 4nnrB-5m99B:14.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5msz | THERMOBIA DOMESTICADOMESTICA AA15 (Thermobiadomestica) |
no annotation | 5 | ASP A 84VAL A 72ILE A 190TYR A 75ILE A 81 | None | 1.07A | 4nnrB-5mszA:undetectable | 4nnrB-5mszA:15.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ueb | NEGOA.19184.A (Neisseriagonorrhoeae) |
PF14085(DUF4265) | 5 | TYR A 123ASP A 83VAL A 76ILE A 74ILE A 88 | None | 1.43A | 4nnrB-5uebA:undetectable | 4nnrB-5uebA:20.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v8t | UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei;Saccharomycescerevisiae) |
no annotation | 9 | TYR A 33ASP A 44PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | 8ZV A 201 (-3.8A)8ZV A 201 (-3.9A)8ZV A 201 (-3.9A)8ZV A 201 (-3.6A)8ZV A 201 (-4.0A)8ZV A 201 (-3.3A)8ZV A 201 (-4.6A)8ZV A 201 ( 4.8A)8ZV A 201 (-4.6A) | 0.32A | 4nnrB-5v8tA:16.3 | 4nnrB-5v8tA:17.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vdk | WEE1-LIKE PROTEINKINASE 2 (Homo sapiens) |
PF00069(Pkinase) | 5 | ILE A 319TYR A 376LYS A 350ILE A 347PHE A 311 | None | 1.13A | 4nnrB-5vdkA:undetectable | 4nnrB-5vdkA:19.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 6 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.13A | 4nnrB-5xb0A:12.4 | 4nnrB-5xb0A:34.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 8 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.75A | 4nnrB-5xb0A:12.4 | 4nnrB-5xb0A:34.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xcy | GLUCANASE (Phanerochaetechrysosporium) |
PF01341(Glyco_hydro_6) | 5 | TYR A 190PHE A 180VAL A 133ILE A 136ILE A 161 | None | 1.28A | 4nnrB-5xcyA:undetectable | 4nnrB-5xcyA:15.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xhw | PUTATIVE6-DEOXY-D-MANNOHEPTOSE PATHWAY PROTEIN (Yersiniapseudotuberculosis) |
no annotation | 5 | TYR A 207VAL A 132ILE A 165TYR A 140ILE A 213 | None | 1.39A | 4nnrB-5xhwA:undetectable | 4nnrB-5xhwA:21.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z0y | SERINEHYDROXYMETHYLTRANSFERASE (Komagataellaphaffii) |
no annotation | 5 | TYR A 339ASP A 418VAL A 393ILE A 395PHE A 334 | None | 1.32A | 4nnrB-5z0yA:undetectable | 4nnrB-5z0yA:22.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 8 | TYR A 38ASP A 49PHE A 58VAL A 67ILE A 68TYR A 94ILE A 103PHE A 111 | None | 0.46A | 4nnrB-6b4pA:15.4 | 4nnrB-6b4pA:40.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 7 | TYR A 38PHE A 58VAL A 67ILE A 68TRP A 71TYR A 94ILE A 99 | None | 1.42A | 4nnrB-6b4pA:15.4 | 4nnrB-6b4pA:40.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 8 | TYR A 38PHE A 58VAL A 67ILE A 68TRP A 71TYR A 94ILE A 103PHE A 111 | None | 0.58A | 4nnrB-6b4pA:15.4 | 4nnrB-6b4pA:40.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6du8 | - (-) |
no annotation | 5 | TYR A 366PHE A 362VAL A 109ILE A 108ILE A 453 | None | 1.43A | 4nnrB-6du8A:undetectable | 4nnrB-6du8A:undetectable |